Eli Lilly and Company (LLY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Company Overview - Eli Lilly is celebrating its 150th anniversary, positioning itself as one of the most valuable long-standing companies in America [2]. Product Pipeline and Developments - The company is entering 2026 with increased certainty regarding its product portfolio, particularly following the successful launch of tirzepatide for obesity treatment [3]. - Eli Lilly has been actively developing follow-on pipeline products, including orforglipron, an oral GLP-1, with Phase III data expected to be discussed further [4].